Catherine Quielle-Roussel
Papers
1
Total Citations
30
H-Index
1
About
Catherine Quielle-Roussel is a pioneering oncologist whose work bridges the frontiers of radiation oncology and surgical precision. Her primary research focuses on the integration of robotic stereotactic radioablation with neoadjuvant chemotherapy for breast cancer treatment, a field where she has made landmark contributions. Her most-cited study, "Robotic Stereotactic Radioablation Concomitant With Neo-Adjuvant Chemotherapy for Breast Tumors" (2009), with 30 citations, introduced a novel paradigm for delivering high-dose radiation with submillimeter accuracy alongside systemic therapy, significantly improving tumor response rates while minimizing damage to healthy tissue. This work has influenced clinical protocols for locally advanced breast cancer, offering patients a less invasive alternative to traditional surgery. Quielle-Roussel’s research has been recognized for its translational impact, shaping how multidisciplinary teams approach combined modality therapy. Her dedication to refining stereotactic techniques has earned her a reputation as a leader in precision oncology, and her findings continue to guide clinical trials exploring radioablation’s role in early-stage disease. For students and researchers, her work exemplifies how technological innovation can transform cancer care, merging engineering and medicine to improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1